CARTing Away Cardiac Fibrosis∗

CARTing Away Cardiac Fibrosis∗

Bibliographic Details
Main Author:	Jonathan A. Epstein, MD
Format:	Article
Language:	English
Published:	Elsevier 2020-03-01
Series:	JACC. CardioOncology
Subjects:	cardiac fibrosis chimeric antigen receptor fibroblast activation protein
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666087320300181

Similar Items

Nuclear Receptor Nur77 Controls Cardiac Fibrosis through Distinct Actions on Fibroblasts and Cardiomyocytes
by: Lejla Medzikovic, et al.
Published: (2021-02-01)

In vivo generated chimeric antigen receptor T cells reduce fibrosis and restore cardiac function in experimental heart failure
by: Liuzzo, G., et al.
Published: (2022)

Cardiac Fibrosis and Cardiac Fibroblast Lineage-Tracing: Recent Advances
by: Xing Fu, et al.
Published: (2020-05-01)

The Dynamic Interplay Between Cardiac Inflammation and Fibrosis
by: Toby P. Thomas, et al.
Published: (2020-09-01)

Editorial: Cardiac Fibrosis, From Lineage Tracing to Therapeutic Application
by: Claudio de Lucia, et al.
Published: (2021-01-01)

Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer
by: Rohtesh S. Mehta, et al.
Published: (2018-02-01)

Glycolysis Inhibition Alleviates Cardiac Fibrosis After Myocardial Infarction by Suppressing Cardiac Fibroblast Activation
by: Zhi-Teng Chen, et al.
Published: (2021-09-01)

Intermittent hypoxia mediated by TSP1 dependent on STAT3 induces cardiac fibroblast activation and cardiac fibrosis
by: Qiankun Bao, et al.
Published: (2020-01-01)

The AP-1 Transcription Factor Fosl-2 Regulates Autophagy in Cardiac Fibroblasts during Myocardial Fibrogenesis
by: Jemima Seidenberg, et al.
Published: (2021-02-01)

The Role of MMP-13 in Cardiac Remodeling and Fibrosis
by: Schafer, Allison E.
Published: (2018)

Synthetic Prostacyclin Agonist Attenuates Pressure-Overloaded Cardiac Fibrosis by Inhibiting FMT
by: Kenta Masada, et al.
Published: (2020-12-01)

MicroRNA-101a Inhibits Cardiac Fibrosis Induced by Hypoxia via Targeting TGFβRI on Cardiac Fibroblasts
by: Xin Zhao, et al.
Published: (2015-01-01)

Targeting Adenosine Receptors for the Treatment of Cardiac Fibrosis
by: Elizabeth A. Vecchio, et al.
Published: (2017-05-01)

Targeting Cancer Stem Cells by Genetically Engineered Chimeric Antigen Receptor T Cells
by: Rowa Y. Alhabbab
Published: (2020-04-01)

Calcium Sensing Receptor Promotes Cardiac Fibroblast Proliferation and Extracellular Matrix Secretion
by: Xinying Zhang, et al.
Published: (2014-02-01)

The Functional Role of Zinc Finger E Box-Binding Homeobox 2 (Zeb2) in Promoting Cardiac Fibroblast Activation
by: Fahmida Jahan, et al.
Published: (2018-10-01)

Cardiac Fibrosis: Key Role of Integrins in Cardiac Homeostasis and Remodeling
by: Patrick B. Meagher, et al.
Published: (2021-03-01)

Piperine Attenuates Pathological Cardiac Fibrosis Via PPAR-γ/AKT Pathways
by: Zhen-Guo Ma, et al.
Published: (2017-04-01)

Trimethylamine N-Oxide Exacerbates Cardiac Fibrosis via Activating the NLRP3 Inflammasome
by: Xueling Li, et al.
Published: (2019-07-01)

CART Immunotherapy: Development, Success, and Translation to Malignant Gliomas and Other Solid Tumors
by: Anna C. Filley, et al.
Published: (2018-10-01)

Long noncoding RNA Cfast regulates cardiac fibrosis
by: Feng Zhang, et al.
Published: (2021-03-01)

Divergent Effects of Resveratrol on Rat Cardiac Fibroblasts and Cardiomyocytes
by: Xavier Lieben Louis, et al.
Published: (2019-07-01)

P2Y1 Receptor Agonist Attenuates Cardiac Fibroblasts Activation Triggered by TGF-β1
by: Geer Tian, et al.
Published: (2021-02-01)

C188‐9 reduces TGF‐β1‐induced fibroblast activation and alleviates ISO‐induced cardiac fibrosis in mice
by: Jiao Liu, et al.
Published: (2021-07-01)

Protective role of berberine in isoprenaline-induced cardiac fibrosis in rats
by: Yan Che, et al.
Published: (2019-10-01)

Scleraxis is a mechanoresponsive regulator of the cardiac myofibroblast phenotype
by: Roche, Patricia
Published: (2015)

Ca2+ Signaling in Cardiac Fibroblasts and Fibrosis-Associated Heart Diseases
by: Jianlin Feng, et al.
Published: (2019-09-01)

Redirected Primary Human Chimeric Antigen Receptor Natural Killer Cells As an “Off-the-Shelf Immunotherapy” for Improvement in Cancer Treatment
by: Olaf Oberschmidt, et al.
Published: (2017-06-01)

Pharmacological Inhibition of Focal Adhesion Kinase Attenuates Cardiac Fibrosis in Mice Cardiac Fibroblast and Post-Myocardial-Infarction Models
by: Guang-Pu Fan, et al.
Published: (2015-09-01)

Cardiac Fibroblasts Mediate a Sexually Dimorphic Fibrotic Response to β‐Adrenergic Stimulation
by: Angela K. Peter, et al.
Published: (2021-06-01)

The role of the monomeric GTPase RhoA in cardiac fibroblasts
by: Jatho, Aline
Published: (2014)

Cellular and molecular mechanisms of cardiac fibrosis.
Published: (2013)

High-Mobility Group A1 Promotes Cardiac Fibrosis by Upregulating FOXO1 in Fibroblasts
by: Qingwen Xie, et al.
Published: (2021-08-01)

Exploring the Role and Therapeutic Potential of Gbeta/gamma-GRK2 Inhibition in Cardiac Fibroblasts, Fibrosis and Remodeling
by: Travers, Joshua G.
Published: (2017)

Effects of the Calcium-Activated Chloride Channel Inhibitors T16Ainh-A01 and CaCCinh-A01 on Cardiac Fibroblast Function
by: Xiang-qin Tian, et al.
Published: (2018-08-01)

Mechanisms of ski-induced apoptosis in cardiac fibroblasts and myofibroblasts
by: Davies, Jared
Published: (2015)

The ER Unfolded Protein Response Effector, ATF6, Reduces Cardiac Fibrosis and Decreases Activation of Cardiac Fibroblasts
by: Winston T. Stauffer, et al.
Published: (2020-02-01)

Mineralocorticoid Receptor Signaling as a Therapeutic Target for Renal and Cardiac Fibrosis
by: Greg H. Tesch, et al.
Published: (2017-05-01)

The Great War of Today: Modifications of CAR-T Cells to Effectively Combat Malignancies
by: Andriy Zhylko, et al.
Published: (2020-07-01)

Beyond CD19: Opportunities for future development of targeted immunotherapy in pediatric relapsed-refractory acute leukemia
by: Haneen eShalabi, et al.
Published: (2015-10-01)